Manatt Represents NeOnc Technologies Holdings in its Direct Listing on the NASDAQ

Manatt Partners , and Associate represented NeOnc Technologies Holdings, a clinical stages life sciences company that develops central nervous system therapeutics created to overcome blood-brain barrier challenges, in its direct listing on the NASDAQ Global Market and private placements of $28.5 million. The company’s common stock trades under the symbol NTHI.

Click to learn more about the company’s addition to the NASDAQ Global Market.